# Smith & Nephew, J&J Orthopaedics Merger Collapses Over Leadership Dispute

> A proposed $34 billion transatlantic merger between UK-listed Smith & Nephew and Johnson & Johnson's orthopaedics unit failed in mid-October 2026 due to disagreement over who would lead the combined company.

By PrimaryBrief newsroom · Published 2026-10-23T04:53:51.858995Z
Canonical: https://primarybrief.com/article/smith-nephew-j-j-orthopaedics-merger-collapses-over-leadership-dispute-4271a166

UK-listed Smith & Nephew and Johnson & Johnson's orthopaedics unit, DePuy Synthes, ended their proposed $34 billion transatlantic merger in mid-October 2026 due to an unresolved dispute over who would lead the combined company [21]. This collapse leaves both medical technology companies to pursue separate strategies, impacting their market positions and future growth in the competitive orthopaedics sector.

## What the records show
The proposed merger aimed to create a $34 billion medical technology company [21][22]. Financial terms were largely agreed upon, with Johnson & Johnson shareholders set to own 50.1% of the new entity and Smith & Nephew investors holding the remainder [21]. Johnson & Johnson's orthopaedics unit, DePuy Synthes, was valued at up to $22 billion within the transaction [21][22].

## The timeline of the dispute
The central point of disagreement was the leadership of the combined company [21][22]. Johnson & Johnson insisted that Namal Nawana, who became worldwide president of DePuy Synthes in October 2025, take the CEO role [1][2][3][4][14][21][22]. Nawana previously served as CEO of Smith & Nephew [2][4][14][20]. Smith & Nephew rejected this condition, instead advocating for its current CEO, Deepak Nath, to remain in charge [15][16][17][18][19][21][22]. Rupert Soames, who became Smith & Nephew's chair in September 2023, declared this leadership demand a "red line" in negotiations [5][6][7][8][9][21][22].

## What changed and for whom
Following the breakdown of merger talks, Johnson & Johnson is now reportedly favoring a spin-off of its orthopaedics unit as a separate publicly traded company by mid-2027 [10][11][12][13][22]. This spin-off plan was initially announced by Johnson & Johnson in October 2025 [10][14]. For Smith & Nephew, its shares have underperformed, dropping 21% over the past 12 months, while the FTSE 100 index rose 13% [21]. The company has also faced pressure from activist investor Cevian Capital, which increased its shareholding to push for operational and strategic changes [21][23]. Shareholder concerns have also been raised regarding CEO Deepak Nath's remuneration package [24][25][26].

## What the companies have said
Johnson & Johnson's finance chief Joe Wolk stated in October 2026 that the company was "leaning towards" spinning off the DePuy Synthes unit as a separate listed group [22]. He credited Namal Nawana for recent performance improvements in the unit [22]. No specific public statements from Smith & Nephew regarding the collapsed merger talks were provided in the evidence.

## What we could not confirm
The specific details of the "advanced stages" of the merger talks beyond financial terms and leadership disagreements were not detailed in the available records [22]. The precise nature of the "operational improvements and strategic changes" sought by activist investor Cevian Capital at Smith & Nephew was not specified [23].

## Evidence cited
1. (October 14 2025) Johnson & Johnson said it appointed Namal Nawana to serve as worldwide president, DePuy Synthes, effective immediately.
...The company expects him to continue leading DePuy Synthes following the completion of the separation. (massdevice.com) — https://massdevice.com/
2. J&J's US orthopedic leader leaves amid DePuy spinout process | HCSA (nhsprocurement.org.uk) — https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHU6ib3b-fi8QiSkSgxTIEViRxzGKrZ2KyoUDocwEQwIMM0u-8ERVv715oEeRKlu_lpnzvufA_QcZZJ_EtiGoCCn_alm-zbOaDlSGaiZ4y8_915DV0EBbALecm7VeoyK68MEZ3FvNqDuAiOhY1o26sdYdpjjghfyX8c9TkuvVS1Ml0eU5tMliaYihkAq8cbW71PD4F8E5CHnRFKnEM=
3. J&J to spin out orthopedics business in 18 to 24 months | BioPharma Dive (biopharmadive.com) — https://biopharmadive.com/
4. J&J's US orthopedics head leaves amid DePuy spinout process | MedTech Dive (medtechdive.com) — https://medtechdive.com/
5. Smith+Nephew Appoints Rupert Soames as Chairman | ODTMag (odtmag.com) — https://odtmag.com/
6. Rupert Soames OBE (cbi.org.uk) — https://www.cbi.org.uk/about-the-cbi/our-people/rupert-soames/
7. Smith+Nephew announces Rupert Soames as Chair Designate - Smith+Nephew (smith-nephew.com) — https://www.smith-nephew.com/news-and-media/news/news-2023/smith--nephew-announces-rupert-soames-as-chair-designate/
8. Rupert Soames OBE (futurecountryside.org) — https://www.futurecountryside.org/rupert-soames
9. Board of Directors | Smith+Nephew (smith-nephew.com) — https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHEhin-lRrpjwMjHF1Zng1I40VAYYGMLI1p1OvrxAdUM6Ft6oBpKvF78-jJbeLMjo9i21D2rpb_fSZQRmhioT7w9G0cCL1_3g28Rg5_MeJhIjsQFnmNJQoNocudPBCA2OXz0btJb9oF7jOIyAhsyvjzR8uB4g-VVCmRAa1rdnZCYBxEBIA4zLFg=
10. Johnson & Johnson deploys spinoff instead of sale for DePuy Synthes - Stock Spinoffs (stockspinoffs.com) — https://stockspinoffs.com/johnson-johnson-deploys-spinoff-instead-of-sale-for-depuy-synthes/
11. J&J targets mid-2027 to separate DePuy Synthes as MedTech sales miss | MedDevice Startups (meddevicestartups.com) — https://meddevicestartups.com/johnson-johnson-targets-mid-2027-to-separate-depuy-synthes/
12. Johnson & Johnson plans to spin off Depuy operations next year (irishexaminer.com) — https://www.irishexaminer.com/business/economy/arid-41246738.html
13. Johnson & Johnson leans toward spin-off for DePuy Synthes - el-fondo (el-fondo.com) — https://el-fondo.com/johnson-johnson-leans-toward-spin-off-for-depuy-synthes/
14. J&J DePuy Synthes: Spin-Off or Sale? (2026 Analysis) (meddeviceguide.com) — https://meddeviceguide.com/johnson-johnson-depuy-synthes-spin-off-sale-2026-analysis/
15. Smith+Nephew Announces New Chief Executive Officer (orthofeed.com) — https://www.orthofeed.com/2022/smith-nephew-announces-new-chief-executive-officer/
16. Deepak Nath | World Economic Forum (weforum.org) — https://www.weforum.org/people/deepak-nath/
17. Deepak Nath | Foro Económico Mundial (weforum.org) — https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHt4X_1Q_EW2-kaIHUjXM_JUprO0pcME9INgNkALgkF9jMohBy65R0-MdtJu8PDPz4-utNVP4-UeztmONjAfNL1Eu6cRgXWLgKmhlh6vFkGLl3kvh_aaRFuIHBuMjVKTlkx-Ujiww==
18. Deepak Nath — CEO of Smith & Nephew, influence & market role | Barfinex (barfinex.com) — https://barfinex.com/profiles/deepak-nath
19. Deepak S. Nath - Biography (marketscreener.com) — https://www.marketscreener.com/business-leaders/Deepak-S-Nath-0H1G2K-E/biography/
20. Johnson & Johnson Announces Intent to Separate Orthopaedics Business (jnj.com) — https://www.jnj.com/media-center/news/johnson-johnson-announces-intent-to-separate-orthopaedics-business
21. Johnson & Johnson and Smith & Nephew Merge Collapse (tradersunion.com) — https://www.tradersunion.com/news/forex-market/brokers-news/johnson-johnson-and-smith-nephew-merge-collapse-10232026/
22. J&J/Smith & Nephew merger talks collapse over leadership dispute (ft.com) — https://www.ft.com/content/1d9600a0-00c7-4348-8316-041441a1a74d
23. Cevian Capital raises Smith & Nephew stake: What does this mean for SN shareholders? (kalkinemedia.com) — https://kalkinemedia.com/uk/news/activist-investors/cevian-capital-raises-smith-nephew-stake-what-does-this-mean-for-sn-shareholders
24. Smith & Nephew shareholders revolt over chief executive’s pay rise | Smith & Nephew | The Guardian (the guardian.com) — https://www.theguardian.com/business/2024/may/01/smith-nephew-shareholders-revolt-over-chief-executives-pay-rise
25. Smith & Nephew concludes further shareholder consultation on remuneration policy (sharecast.com) — https://www.sharecast.com/news/aim-news/smith--nephew-concludes-further-shareholder-consultation-on-remuneration-policy--15978135.html
26. Smith & Nephew Grants CEO Nath Share Awards After Shareholder Consultation (investing.com) — https://www.investing.com/news/stock-market-news/smith--nephew-grants-ceo-nath-share-awards-after-shareholder-consultation-432SI2579133